Kangmei Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 3,534.12 million compared to CNY 2,721.81 million a year ago. Revenue was CNY 3,534.12 million compared to CNY 2,721.81 million a year ago.

Net loss was CNY 148.01 million compared to CNY 885.77 million a year ago. Basic loss per share from continuing operations was CNY 0.011 compared to CNY 0.064 a year ago. Diluted loss per share from continuing operations was CNY 0.011 compared to CNY 0.064 a year ago.